What is the main purpose of this 8-K filing?

This 8-K filing announces Axon Enterprise, Inc.'s decision to redeem all of its outstanding 0.50% convertible senior notes due 2027, providing details on the redemption process and the options available to noteholders.

What are my options as a holder of the 0.50% convertible senior notes due 2027?

As a noteholder, you have two primary options: (1) Surrender your notes for redemption on February 10, 2026, and receive 100% of the principal amount plus accrued interest, or (2) Convert your notes into Axon common stock prior to the close of business on February 6, 2026. The conversion settlement will involve a cash payment for the principal portion and shares of common stock for any amount above the principal.

How will the conversion settlement amount be determined if I choose to convert my notes?

If you choose to convert your notes, the settlement amount will be determined by Axon over a 30-trading day observation period, which begins on December 24, 2025, and concludes on February 6, 2026. The actual settlement, including cash and shares of common stock, will be delivered on February 10, 2026.

Why might Axon be redeeming these notes?

Companies typically redeem convertible notes for several reasons, including to reduce interest expenses, manage their debt obligations, or to optimize their capital structure. It can also be a strategy to de-lever their balance sheet or to avoid future dilution if the stock price has performed well, making conversion more likely.

AXON 8-K SEC Disclosure

Summary

Axon Enterprise, Inc. has announced its intention to redeem all outstanding 0.50% convertible senior notes due 2027 on February 10, 2026. The redemption price will be 100% of the principal amount plus accrued and unpaid interest. This action signals a proactive approach by Axon to manage its debt obligations, potentially to reduce future interest expenses or optimize its capital structure. Investors holding these notes should be aware of the redemption timeline and their option to convert their notes into Axon common stock before February 6, 2026. The conversion settlement amount will be determined based on a 30-trading day observation period, providing a mechanism for shareholders to benefit from potential stock appreciation prior to conversion. The redemption of these notes is a significant event that could impact the company's balance sheet and future financial flexibility.

Key Highlights

1Axon Enterprise, Inc. is redeeming all outstanding 0.50% convertible senior notes due 2027.
2The redemption date is scheduled for February 10, 2026.
3The redemption price is set at 100% of the principal amount plus accrued and unpaid interest.
4Noteholders have the option to convert their notes into Axon common stock until February 6, 2026.
5The settlement amount for conversions will be determined over a 30-trading day observation period starting December 24, 2025, and ending February 6, 2026.
6Settlement for converted notes will occur on the redemption date, February 10, 2026.
7The company will pay cash for the principal portion and deliver common stock for amounts exceeding the principal upon conversion.

AXON ENTERPRISE, INC. 8-K Report, Corporate Update (Dec 18, 2025)

Summary

Key Highlights

Frequently Asked Questions